Healthy Aging at 70 and Beyond: The Evidence-Based Guide to the Later Decades
The longevity medicine conversation is often implicitly aimed at adults in their 30s to 50s — people investing in a future they can meaningfully shape. But a large fraction of the audience for longevity science is already in their 60s, 70s, and 80s — seeking not to reverse decades of choices but to make the most of the biology they have. The evidence for maintaining and improving health, cognition, and function in the later decades is compelling and genuinely encouraging.
- The most important message for adults over 70: it is never too late to benefit meaningfully from lifestyle intervention. Multiple RCTs in adults over 70, 75, and even 80 have demonstrated significant improvements in muscle mass, cardiovascular fitness, cognitive function, and inflammatory biomarkers from resistance training, aerobic exercise, dietary optimization, and targeted supplementation.
- Sarcopenia — the age-related loss of muscle mass and function — is the single most important modifiable longevity risk in adults over 70. It predicts falls, fractures, hospitalization, functional decline, and all-cause mortality more powerfully than most other biomarkers in older populations. Resistance training at any age produces measurable muscle mass gains in older adults, including those in their 80s.
- Polypharmacy — the use of 5 or more medications simultaneously, affecting over 40 percent of adults over 65 — is itself a significant health risk. Drug-drug interactions, drug-disease interactions, and cumulative side effects (sedation, orthostatic hypotension, constipation, cognitive impairment) are common and frequently unrecognized as medication-related. Annual comprehensive medication review with a pharmacist or geriatrician is one of the highest-value interventions for older adults.
- Protein requirements increase with aging due to anabolic resistance — older adults require more protein per meal to achieve the same muscle protein synthesis response as younger adults. The evidence-based recommendation for adults over 70: 1.6-2.0 g/kg/day distributed across at least 3 meals, with each meal containing 35-40 grams of high-quality protein and at least 3 grams of leucine.
- Fall prevention is a critical longevity intervention in adults over 70: falls are the leading cause of injury-related death in this age group, and hip fracture carries 20-30 percent one-year mortality. The most effective evidence-based fall prevention strategy is progressive balance and strength training (the Otago Exercise Programme has the strongest RCT evidence), combined with home safety modification, medication review for fall-risk medications, and vision correction.
The discourse around longevity medicine carries an implicit assumption that its audience is primarily young and middle-aged — that the most meaningful investment is in prevention decades before disease manifests. This framing is correct but incomplete. Adults in their 70s and 80s have a different but equally important longevity opportunity: optimizing function, independence, and healthspan in the years they have, and slowing the functional decline that transitions healthy old age into dependent old age. The evidence for meaningful intervention in the later decades is both more robust and more encouraging than is commonly understood.1
Resistance Training in Older Adults: The Most Important Intervention
Sarcopenia — the progressive loss of skeletal muscle mass and strength with aging — is the most powerful predictor of functional decline and mortality in older adults that is directly modifiable. It predicts falls and fractures (muscle weakness is the primary cause of falls), hospitalization rates, recovery time from illness and surgery, functional independence (the ability to live independently), and all-cause mortality. The good news: skeletal muscle is extraordinarily responsive to resistance training stimulus even in very old adults. Multiple RCTs have demonstrated significant increases in muscle mass, strength, and functional performance from resistance training in adults over 80, including those with frailty.2
The minimum effective dose for sarcopenia prevention and reversal: 2 to 3 sessions per week of progressive resistance exercise targeting major muscle groups, with loads at 60 to 80 percent of one-repetition maximum (or, for those who cannot safely perform loaded exercises, high-repetition lower-load training to fatigue). Protein intake must be co-optimized — resistance training without adequate protein (35 to 40 grams per meal, 3 meals per day) produces substantially less muscle mass gain in older adults than the combination. The LIFTMOR trial established that even high-intensity resistance training is safe and effective in older adults with osteopenia, when supervised appropriately.
Polypharmacy: The Silent Longevity Threat
Polypharmacy — defined as the simultaneous use of 5 or more medications — affects over 40 percent of adults over 65 and over 60 percent of adults over 75 in developed countries. Each additional medication adds the possibility of drug-drug interactions, drug-disease interactions, and cumulative adverse effects. The consequences are often misattributed to aging rather than medication: cognitive impairment from anticholinergic drugs (many antihistamines, overactive bladder medications, certain antidepressants), orthostatic hypotension from antihypertensives (the leading medication-related cause of falls), sedation and falls from benzodiazepines and Z-drugs, and delirium from opioids.3
The Beers Criteria (American Geriatrics Society) identifies medications with potentially inappropriate use in older adults — a list that includes dozens of commonly prescribed medications. Annual medication review with a geriatrician, clinical pharmacist, or informed primary care physician using a deprescribing framework is one of the highest-value interventions available to older adults taking multiple medications. Reducing polypharmacy frequently improves cognition, fall risk, quality of life, and hospitalizations.
Cardiovascular Medicine in Older Adults: Age-Specific Calibration
The evidence base for cardiovascular risk factor treatment requires recalibration in very old adults. Intensive blood pressure treatment (target below 120 mmHg systolic) produces significant cardiovascular event reduction in adults over 75 — the SPRINT trial subgroup analysis confirmed this — but carries higher rates of orthostatic hypotension, falls, and acute kidney injury. Statin therapy for secondary prevention (established cardiovascular disease) remains clearly beneficial in adults over 75. Primary prevention statin therapy in adults over 80 without established cardiovascular disease is less well-supported. These are individualized decisions requiring consideration of functional status, life expectancy, and treatment burden.4
Cognitive Reserve: The Lifelong Investment That Pays Off in Old Age
Cognitive reserve — the brain's resilience against the effects of Alzheimer's pathology and age-related neurodegeneration — is built across a lifetime through education, intellectual engagement, bilingualism, social connection, and physical activity. People with high cognitive reserve can tolerate substantially higher amounts of Alzheimer's pathology before showing clinical symptoms — meaning that the brain investments of a lifetime delay the onset of dementia even as neuropathology accumulates. For older adults, the activities that build ongoing cognitive reserve include: learning new complex skills (musical instruments, second languages, complex crafts), social engagement that requires active cognitive processing, and physical exercise (which continues to produce BDNF and neurogenesis at any age).5
References
- 1Fiatarone MA, et al. "Exercise training and nutritional supplementation for physical frailty in very elderly people." NEJM. 1994;330(25):1769-1775. [PubMed]
- 2Peterson MD, et al. "Resistance exercise for muscular strength in older adults: a meta-analysis." Ageing Research Reviews. 2010;9(3):226-237. [PubMed]
- 3Maher RL, et al. "Clinical consequences of polypharmacy in elderly." Expert Opinion on Drug Safety. 2014;13(1):57-65. [PubMed]
- 4Williamson JD, et al. "Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged 75 years." JAMA. 2016;315(24):2673-2682. [PubMed]
- 5Stern Y. "Cognitive reserve in ageing and Alzheimer's disease." Lancet Neurology. 2012;11(11):1006-1012. [PubMed]